{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:20:13Z","timestamp":1771050013253,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.micpath.2022.105482","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T20:47:19Z","timestamp":1647031639000},"page":"105482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Convalescent plasma therapy in patients with severe COVID-19, A single-arm, retrospective study"],"prefix":"10.1016","volume":"165","author":[{"given":"Ladan","family":"Ghadami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Hasibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Asadollahi-Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behzad","family":"asanjarani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Farahmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"514","key":"10.1016\/j.micpath.2022.105482_bib1","article-title":"A review on COVID-19: the epidemiology, transmission, impact on pregnancy and reproductive Health and its prevention","volume":"10","author":"Wadood","year":"2021","journal-title":"J. Women's Health Care"},{"key":"10.1016\/j.micpath.2022.105482_bib2","unstructured":"Worldometers.info. COVID-19 CORONAVIRUS PANDEMIC Dover, Delaware, U.S.A. 2021 [updated 31 August, 2021. Available from: https:\/\/www.worldometers.info\/coronavirus\/."},{"issue":"19","key":"10.1016\/j.micpath.2022.105482_bib3","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.micpath.2022.105482_bib5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa2033700","article-title":"Early high-titer plasma therapy to prevent severe covid-19 in older adults","volume":"384","author":"Libster","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2022.105482_bib27","series-title":"StatPearls","article-title":"Features, Evaluation, and Treatment of Coronavirus (COVID-19)","author":"Cascella","year":"2022"},{"key":"10.1016\/j.micpath.2022.105482_bib6","doi-asserted-by":"crossref","first-page":"107262","DOI":"10.1016\/j.intimp.2020.107262","article-title":"Convalescent plasma may be a possible treatment for COVID-19: a systematic review","volume":"91","author":"Wang","year":"2021","journal-title":"Int. Immunopharm."},{"issue":"3","key":"10.1016\/j.micpath.2022.105482_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/tme.12746","article-title":"Convalescent plasma therapy for the treatment of patients with COVID-19: assessment of methods available for antibody detection and their correlation with neutralising antibody levels","volume":"31","author":"Harvala","year":"2021","journal-title":"Transfus. Med."},{"issue":"1","key":"10.1016\/j.micpath.2022.105482_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.706","article-title":"Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential","volume":"22","author":"Coughlin","year":"2012","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.micpath.2022.105482_bib9","series-title":"Neutralizing Antibody Responses to SARS-CoV-2 in a COVID-19 Recovered Patient Cohort and Their Implications","author":"Wu","year":"2020"},{"issue":"9","key":"10.1016\/j.micpath.2022.105482_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140200","article-title":"Early safety indicators of COVID-19 convalescent plasma in 5000 patients","volume":"130","author":"Joyner","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.micpath.2022.105482_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1179\/1465313313Y.0000000048","article-title":"Clinical trial design for orthodontists","volume":"40","author":"Pandis","year":"2013","journal-title":"J. Orthod."},{"key":"10.1016\/j.micpath.2022.105482_bib12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cca.2020.08.019","article-title":"Laboratory findings in COVID-19 diagnosis and prognosis","volume":"510","author":"Pourbagheri-Sigaroodi","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"10223","key":"10.1016\/j.micpath.2022.105482_bib13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"issue":"10223","key":"10.1016\/j.micpath.2022.105482_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.micpath.2022.105482_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","volume":"52","author":"Hung","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.micpath.2022.105482_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820979921","article-title":"Effectiveness of convalescent plasma therapy for COVID-19 patients in Hunan, China","volume":"18","author":"Hu","year":"2020","journal-title":"Dose Response"},{"issue":"1","key":"10.1016\/j.micpath.2022.105482_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41392-020-00329-x","article-title":"The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multicenter case series","volume":"5","author":"Zeng","year":"2020","journal-title":"Signal Trans. Targeted Ther."},{"issue":"17","key":"10.1016\/j.micpath.2022.105482_bib18","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"1","key":"10.1016\/j.micpath.2022.105482_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000512592","article-title":"Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis","volume":"64","author":"Biswas","year":"2021","journal-title":"Intervirology"},{"issue":"1","key":"10.1016\/j.micpath.2022.105482_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/infdis\/jiaa228","article-title":"Effect of convalescent plasma therapy on viral shedding and survival in patients with coronavirus disease 2019","volume":"222","author":"Zeng","year":"2020","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.micpath.2022.105482_bib21","series-title":"Convalescent Plasma for Patients with Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study","author":"Rogers","year":"2020"},{"key":"10.1016\/j.micpath.2022.105482_bib22","series-title":"Early Transfusion of a Large Cohort of COVID-19 Patients with High Titer Anti-SARS-CoV-2 Spike Protein IgG Convalescent Plasma Confirms a Signal of Significantly Decreased Mortality","author":"Salazar","year":"2020"},{"issue":"5","key":"10.1016\/j.micpath.2022.105482_bib23","doi-asserted-by":"crossref","first-page":"102875","DOI":"10.1016\/j.transci.2020.102875","article-title":"Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: results of a multicenter clinical study","volume":"59","author":"Abolghasemi","year":"2020","journal-title":"Transfus. Apher. Sci."},{"issue":"10","key":"10.1016\/j.micpath.2022.105482_bib24","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/infdis\/jiaa505","article-title":"Severe acute respiratory syndrome coronavirus 2 neutralizing antibody titers in convalescent plasma and recipients in New Mexico: an open treatment study in patients with coronavirus disease 2019","volume":"222","author":"Bradfute","year":"2020","journal-title":"J. Infect. Dis"},{"issue":"15","key":"10.1016\/j.micpath.2022.105482_bib25","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/cid\/ciaa351","article-title":"Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19)","volume":"71","author":"Xu","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2022.105482_bib26","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/jmv.26280","article-title":"Duration of SARS\u2010CoV\u20102 RNA shedding and factors associated with prolonged viral shedding in patients with COVID\u201019","volume":"93","author":"Li","year":"2021","journal-title":"J. Med. Virol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102200095X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102200095X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:40:46Z","timestamp":1760110846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088240102200095X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":26,"alternative-id":["S088240102200095X"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2022.105482","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Convalescent plasma therapy in patients with severe COVID-19, A single-arm, retrospective study","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2022.105482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105482"}}